Home Top Movers How Come Ovid Therapeutics Is On The Rise Today?

How Come Ovid Therapeutics Is On The Rise Today?

Price of the biopharmaceutical company Ovid Therapeutics Inc. (NASDAQ: OVID) is on an uptick in early trades today. The stock was at a rise of +47.13% to $4.36 as of 11:09 a.m. EST followed by news of a global rights deal struck by the company.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What does the deal say?


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Ovid Therapeutics Inc. is a New York-based biopharmaceutical company that is transforming the lives of patients with rare neurological disorders developing treatments through its BoldMedicine approach.

Read More

There are many potential first-in-class medicines in the pipeline at Ovid.

Angelman syndrome, Fragile X syndrome, and rare epilepsies are among these programs, as are programs targeting other monogenetic disorders, which are in their early stages.

Announced today is a new exclusive agreement has been concluded between Takeda Pharmaceutical Company Limited (NYSE:TAK) and Ovid.

  • Under the terms of the agreement, Takeda will secure global rights on closing from Ovid for the development and commercialization of the investigational drug soticlestat targeted against Dravet syndrome (DS) and Lennox Gastaut syndrome (LGS).
  • Soticlestat is the first-in-class inhibitor of cholesterol 24-hydroxylase (CH24H) discovered at Takeda Research Center in Shonan, Japan.
  • Takeda has secured all global rights to soticlestat from Ovid under the new exclusive agreement.
  • It will be Takeda’s sole responsibility to move forward with further development and commercialization throughout the world.
  • Ovid will no longer be held responsible for any future milestone payments or development and commercialization costs due to Takeda under the original collaboration agreement.
  • In addition to the $196 million upfront payment at closing, Ovid may receive an additional $660 million upon reaching milestones in the development, regulatory, and sales phases of the transaction.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

  • In addition, tiered royalties of 11% to 20% will be paid to Ovid if the FDA approves soticlestat and if it is commercialized.
  • Close of the agreement is expected to take place by the end of this month, subject to the satisfaction of regulatory requirements, including the Hart-Scott-Rodino Act.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why Is BTZI Stock Increasing Today?

The stock price of BOTS, Inc. (OTCPink: BTZI) has been rising more than 7% today and was buoying at $0.1266 at the last check....

Why Has The KBSF Stock Price Gained 10% In Last Session?

As of Friday's normal trading session, the price of KBS Fashion Group Limited (NASDAQ: KBSF) rose $0.26 or 9.96% to conclude at $2.87. KBS...

Why Royal Bank of Canada (RY) stock plummeted in after-hours on Friday?

Royal Bank of Canada (RY) stock lost 64.36% in the extended hour trading session on Friday, April 16, 2021. The RY stock gained merely...

Why Did The CMCL Stock Rise By 8% In Last Trading?

Caledonia Mining Corporation Plc (NYSE: CMCL) gained 8.91% during the trading session on Thursday. The share price reached a low of $13.70 and a...

Why Progyny Inc (PGNY) stock gained on Thursday, April 15?

Progyny Inc (PGNY) stock gained 7.31% in the after-hours session on Thursday, April 15, 2021, after it gained 0.94% in the early session.  PGNY...

Is This Why The APLD Stock Skyrocketed Last Trading?

Applied Science Products, Inc. (OTCPK: APLD) closed at $0.635 and experienced a 215.92% increase on Friday. A total of 2.07M shares of Applied Science...

The CRSS Stock Increased 82% In The Last Session Due To What?

Stock of Crossroads Systems, Inc. (OTCQX: CRSS) gained 81.82% or $18.00 in Friday's trading session, closing the day at $40.00 a share. Crossroads Systems...

How Did The ZVO Stock Appreciate 9% In The Last Trading Session?

Zovio Inc (NASDAQ: ZVO) normally sees about 413.34K shares traded on a regular business day but on a Friday it saw a bit higher...

Related News

What Was The Basis Of THRY Stock Rising 9% On Friday?

The stock price of Thryv Holdings, Inc. (NASDAQ: THRY) as of the previous market close was up9.71% to $23.90, with its trading volume at...

Clover Health Investments Corp (CLOV) stock had a “Good Friday”

Clover Health Investments Corp. (CLOV) shares gained 2.38% in the after-market on Friday, April 16, 2021. CLOV's stock gained 20.00% in the normal trading...

Here is why AnPac Bio-Medical Science Co Ltd (ANPC) stock turnaround on Friday

AnPac Bio-Medical Science Co. Ltd. (ANPC) shares surged 28.4% to trade at $6.42 in after-market on Friday, April 16, 2021. ANPC's stock lost -10.71%...

Will It Boost The GMBL Stock Today?

In premarket trading today, the shares of Esports Entertainment Group Inc. (NASDAQ: GMBL) were on the rise. The Esports stock fell by -5.06% to close...

How Did The KXIN Stock Rise In The Last Session?

On Thursday, more than 15.02 million shares of Kaixin Auto Holdings (NASDAQ: KXIN) were traded, and the closing share price was $2.56, an increase...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.